Recurrent Adult Soft Tissue Sarcoma Completed Phase 2 Trials for Perifosine (DB06641)

IndicationStatusPhase
DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00064324Perifosine in Treating Patients With Advanced Soft Tissue SarcomaTreatment